Smart-Money SignalNeutral · 48/100— Insider open-market flow is flat over 90 days
Revenue$139.5M
Net Income-$9.5M
EPS$-0.06
Market Cap$1.6B
Price Performance
Historical data including institutional events
Company Profile
J
John C. Jacobs
CEO & Executive Director
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.
